Chemoradiotherapy as adjuvant treatment of gastric cancer

Annals of Oncology

Volumn 18, Issue SUPPL. 6, 2007, Pages

  Orditura, Michele ^a   Martinelli, E ^a   Galizia, G ^a   Vitiello, F ^a   Fasano, M ^a   Muto, P ^b   Ciardiello, F ^a   De Vita, F ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Division of Radiation Therapy   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; METHOTREXATE; MITOMYCIN C; PACLITAXEL; PLATINUM COMPLEX; SEMUSTINE; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADVANCED CANCER; ANOREXIA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONFERENCE PAPER; DIARRHEA; DISEASE FREE SURVIVAL; DRUG FATALITY; DRUG MEGADOSE; DRUG RESPONSE; GRANULOCYTOPENIA; HIGH RISK PATIENT; HUMAN; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH SURGERY; SURVIVAL RATE; SURVIVAL TIME; ADJUVANT CHEMOTHERAPY; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; STOMACH TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; STOMACH NEOPLASMS;

EID: 35748984710     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm242     Document Type: Conference Paper

References (29)

1. Terry M, Gaudet MM, Gammon MD. The epidemiology of gastric cancer. Semin Radiat Oncol 2002; 12: 111-127.
2. Sakamoto J, Morita S, Kodera Y et al. Adjuvant chemotherapy for gastric cancer in Japan: Global and Japanese perspectives. Cancer Chemother Pharmacol 2004; 54 (Suppl 1): S25-S31.
3. Reis Lag EM, Kosary CL. SEER Cancer Statistic Review 1975-2002. Bethesda, MD: National cancer Institute. http://seer.cancer.gov/csr/ 1975-2002/posted.
4. Gunderson LL. Gastric cancer patterns of relapse resection. Semin Radiat Oncol 2002; 12: 150-161.
5. Robertsn CS, Chung SC, Woods SD et al. A prospective randomized trial comparing R1 subtotal gasctrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994; 220: 176-182.
6. Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy carcinoma. Br J Surg 1988; 75: 110-112.
7. Bonenkamp JJ, Hermans J, Sasako M et al. Extended lymph-node dissection for gastric cacner. Dutch Gastric Cancer Group. N Engl J Med 1999; 340: 908-914.
8. Wu CW, Hsiung CA, Lo SS et al. Nodal dissection for patients with gastric cancer: A randomized trial. Lancet Oncol 2006; 7(4): 309-315.
9. Maruyama K, Sasako M, Kinoshita T et al. Should systematic lymph node dissection be recommended for gastric cancer? Eur J Cancer 1998; 34: 1480-1489.
10. Allum WH, Hallissey MT, Ward LC et al. A controlled, prospective, randomized trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: Interim report. Br J cancer 1989; 60: 739-744.
11. Allum WH, Hallissey MT, Kelly KA. Adjuvant chemotherapy in operable gastric cancer: 5 year follow-up of first British Stomach Cancer Group trial. Lancet 1989; 1: 571-574.
12. Macdonald JS, Fleming TR, Peterson RF et al. Adjuvant chemotherapy with 5-FU, adriamycic, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study. Ann Surg Oncol 1995; 2: 488-494.
13. Hermans J, Bonenkamp JJ, Boon MC et al. Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials. J Clin Oncol 1993; 11: 1441-1447.
14. De Vita F, Giuliani F, Orditura M et al. Adjuvant chemotherapy with ELFE regimen in resected gastric cancer patients: A randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM). Ann Oncol; (In press.).
15. Ann Oncol; (In press).
16. Cunningham D, Allum DH, Stenning SP. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of randomized, controlled trial, ISRCTN. J Clin Oncol 2005; 23: 308s (Abstr).
17. Hallissey MT, Dunn JA, Ward LC et al. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in respectable gastric cancer: Five-year follow-up. Lancet. 1994; 343: 1309-1312.
18. Moerte CG, Childs DS, O'Fallon JR et al. Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol 1984; 2: 1249-1254.
19. Macdonald JS, Smalley SR, Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach. N Engl J Med 2001; 345: 725-730.
20. Kollmannsberger C, Budach W, Stahl M et al. Adjuvant chemoradiation using 5-fluorouracil/folinic acid (cisplatin with or without paclitaxel and radiation inpatinets with completely resected high-risk gastric cancer: Two cooperative phase II studies of the AIO/ARO/ACO. Ann of Oncol 2005; 16: 1326-1333.
21. Alberts SR, Cervantes A, van de Velde CJH. Gastric cancer: Epidemiology, pathology and treatment. Ann Oncol 2003; 14 (Suppl 2): Ii31-ii36.
22. Karpeh MS, Kelsen DP, Tepper JE. Cancer of the stomach. In DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. 4th edn. Philadelphia, PA: Lippincott, Williams and Wilkins 1993; 1092-1122.
23. Kohne CH, Wils JA, Wilke HJ. Developments in the treatment of gastric cancer in Europe. Oncology (Hunting) 2000; 14 (12 Suppl 14): 22-25.
24. Wakui A. Docetaxel-based chemotherapy in the treatment of gastric cancer. J Jpn Soc Cancer Ther 1992; 27: 2029-2035.
25. Cascinu S, Labianca R, Alessandroni P et al. Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, gluthatione, and filgastrim: Report from Italian Group for the Study of Digetsive tract cancer. J Clin Oncol 1997; 11: 3313-3319.
26. Findlay M, Cunningham D, Normann A et al. A phase II study in advanced gastric cancer using epirubicin and cisplatin in combination with continous 5-FU (ECF). Ann Oncol 1994; 5: 609-616.
27. Webb A, Cunningham D, Howard Scarffe J et al. Randomized trial comparing Epirubicin, Cisplatin and Fluorouracil versus Fluorourcail, Doxorubicin, and Methoterxate in advanced esophagogastric cancer. J Clin Oncol 1997; 15: 261-267.
28. Moertel CG, Childs DS, Reitemeier RJ et al. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969; 2: 865-867.
29. Bleiberg H, Goffin JC, Dalesio O et al. Adjuvant radiotherapy and chemotherapy in respectable gastric cancer. A randomized trial of gastro-intestinal tract cancer cooperative group of the EORTC. Eur J Surg Oncol 1989; 15: 535-543.